Quality of Reporting of Randomized Trials as a Measure of Methodologic Quality
Top Cited Papers
Open Access
- 5 June 2002
- journal article
- quality issues-and-standards
- Published by American Medical Association (AMA) in JAMA
- Vol. 287 (21) , 2801-2804
- https://doi.org/10.1001/jama.287.21.2801
Abstract
ContextThe evaluation of the methodologic quality of randomized controlled trials (RCTs) is central to evidence-based health care. Important methodologic detail may, however, be omitted from published reports, and the quality of reporting is therefore often used as a proxy measure for methodologic quality. We examined the relationship between reporting quality and methodologic quality of published RCTs.MethodsStudy of 60 reports of placebo-controlled trials published in English-language journals from 1985 to 1997. Reporting quality was measured using a 25-item scale based on the 1996 issue of the Consolidated Standards of Reporting Trials (CONSORT). Concealment of allocation, appropriate blinding, and analysis according to the intention-to-treat principle were indicators of methodologic quality. Methodologic quality was compared between groups of trials defined by reporting quality scores of low, intermediate, and high. Reporting quality scores were compared between groups defined by high and low methodologic quality.ResultsAmong 23 trials of low reporting quality (median score, 9 [range, 3.5-10.5]), allocation concealment was unclear for all but 1 trial, but there were 16 trials (70%) with adequate blinding and 9 trials (39%) that had been analyzed according to the intention-to-treat principle. Among 18 trials of high reporting quality (median score, 18 [range 16.5-22.0]), there were 8 trials (44%) with adequate allocation concealment, 16 trials (89%) with adequate blinding, and 13 trials (72%) analyzed according to the intention-to-treat principle. The median reporting score was 15.0 for the 33 trials that were analyzed according to intention-to-treat principle and 14.5 for the 14 trials with on-treatment analyses (P = .67).ConclusionsSimilar quality of reporting may hide important differences in methodologic quality, and well-conducted trials may be reported badly. A clear distinction should be made between these 2 dimensions of the quality of RCTs.Keywords
This publication has 11 references indexed in Scilit:
- Systematic reviews in health care: Assessing the quality of controlled clinical trialsBMJ, 2001
- Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials.JAMA, 2001
- The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized TrialsJAMA, 2001
- The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and ElaborationAnnals of Internal Medicine, 2001
- What is meant by intention to treat analysis? Survey of published randomised controlled trialsBMJ, 1999
- Language bias in randomised controlled trials published in English and GermanThe Lancet, 1997
- Improving the quality of reporting of randomized controlled trials. The CONSORT statementJAMA, 1996
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996
- Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trialsJAMA, 1995
- A quality assessment of randomized control trials of primary treatment of breast cancer.Journal of Clinical Oncology, 1986